查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
單光子發射電腦斷層掃描(SPECT)市場報告：至2030年的趨勢、預測和競爭分析
市場調查報告書
商品編碼
1356922

單光子發射電腦斷層掃描(SPECT)市場報告：至2030年的趨勢、預測和競爭分析

Single-Photon Emission Computed Tomography (SPECT) Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

單光子發射電腦斷層掃描（SPECT）的趨勢與預測

到2030年，全球單光子發射電腦斷層掃描（SPECT）市場預計將達到 105 億美元，2024年至2030年年複合成長率為 10.0%。該市場的主要促進因素是醫療保健行業的快速成長，包括惡性腫瘤和心血管在內的惡性疾病盛行率的上升以及對雙模式和器官特異性系統的日益偏好。全球單光子發射電腦斷層掃描（SPECT）市場的未來前景廣闊，醫院、影像影像中心和門診手術中心市場存在商機。

單光子發射電腦斷層掃描（SPECT）市場洞察

  • Lucintel 預測，由於其在腫瘤學和心血管部門的高使用率，獨立 SPECT 預計將在預測期內實現高速成長。
  • 在這個市場中，由於入院患者數量不斷增加以及該機構擴大採用 SPECT 設備進行診斷，醫院將繼續成為最大的細分市場。
  • 由於人口老化以及心臟病和癌症患者數量的增加，預計北美在預測期內將出現最高的成長。

本報告回答了 11 個關鍵問題：

  • Q.1.細分市場中最有前途和高成長的機會為何？
  • Q.2.哪個細分市場將以更快的速度成長？理由為何？
  • Q.3.哪些地區未來會出現更快的成長？理由為何？
  • Q.4.影響市場動態的主要因素有哪些？市場的主要挑戰和商業風險是什麼？
  • Q.5.這個市場的商業風險和競爭威脅為何？
  • Q.6.這個市場有哪些新趨勢？理由為何？
  • Q.7.市場客戶需求有何改變？
  • Q.8.該市場有哪些新發展以及哪些公司處於領先地位？
  • Q.9.這個市場的主要企業有哪些？主要企業採取哪些策略配合措施來發展業務？
  • Q.10.該市場上的競爭產品有哪些？由於材料或產品替代而導致市場佔有率下降的威脅有多大？
  • Q.11.過去年度發生了哪些併購事件，對產業產生了哪些影響？

目錄

第1章 執行摘要

第2章 全球單光子發射電腦斷層掃描（SPECT）市場：市場動態

  • 簡介、背景、分類
  • 供應鏈
  • 產業促進因素與挑戰

第3章 2018-2030年市場趨勢及預測分析

  • 宏觀經濟趨勢（2018-2023）與預測（2024-2030）
  • 全球單光子發射電腦斷層掃描（SPECT）市場趨勢（2018-2023）與預測（2024-2030）
  • 全球單光子發射電腦斷層掃描（SPECT）市場，依產品
    • 獨立SPECT
    • 混合SPECT
  • 全球單光子發射電腦斷層掃描（SPECT）市場，依應用
    • 心臟病學
    • 腫瘤學
    • 一般影像處理
    • 神經病學
    • 其他
  • 全球單光子發射電腦斷層掃描（SPECT）市場，依最終用途
    • 醫院
    • 影像診斷中心
    • 門診手術中心
    • 其他

第4章 2018-2030年市場趨勢及預測分析，依地區

  • 全球單光子發射電腦斷層掃描（SPECT）市場，依地區
  • 北美單光子發射電腦斷層掃描（SPECT）市場
  • 歐洲單光子發射電腦斷層掃描（SPECT）市場
  • 亞太地區單光子發射電腦斷層掃描（SPECT）市場
  • 其他地區單光子發射電腦斷層掃描（SPECT）市場

第5章 競爭分析

  • 產品系列分析
  • 營運整合
  • 波特五力分析

第6章 成長機會與策略分析

  • 成長機會分析
    • 全球單光子發射電腦斷層掃描（SPECT）市場成長機會，依產品
    • 全球單光子發射電腦斷層掃描（SPECT）市場成長機會，依應用
    • 全球單光子發射電腦斷層掃描（SPECT）市場成長機會，依最終用途
    • 全球單光子發射電腦斷層掃描（SPECT）市場成長機會，依地區
  • 全球單光子發射電腦斷層掃描（SPECT）市場的新興趨勢
  • 戰略分析
    • 新產品開發
    • 全球單光子發射電腦斷層掃描（SPECT）市場容量擴張
    • 全球單光子發射電腦斷層掃描（SPECT）市場的合併、收購和合資企業
    • 認證和許可

第7章 主要企業概況

  • Siemens Healthineers
  • Bruker
  • Toshiba Medical
  • Digirad
  • Esaote
  • Invicro
  • GE Healthcare
簡介目錄

Single-Photon Emission Computed Tomography (SPECT) Trends and Forecast

The future of the global single-photon emission computed tomography (SPECT) market looks promising with opportunities in the hospital, diagnostic imaging center, and ambulatory surgical center markets. The global single-photon emission computed tomography (SPECT) market is expected to reach an estimated $10.5 billion by 2030 with a CAGR of 10.0% from 2024 to 2030. The major drivers for this market are rapid growth in healthcare industry, rising prevalence of chronic diseases, including malignancies and cardiovascular, and increasing preference for dual-modality and organ-specific systems.

A more than 150-page report is developed to help in your business decisions.

Single-Photon Emission Computed Tomography (SPECT) by Segment

The study includes a forecast for the global single-photon emission computed tomography (SPECT) by product, application, end use, and region.

Single-Photon Emission Computed Tomography (SPECT) Market by Product [Shipment Analysis by Value from 2018 to 2030]:

  • Standalone SPECT
  • Hybrid SPECT

Single-Photon Emission Computed Tomography (SPECT) Market by Application [Shipment Analysis by Value from 2018 to 2030]:

  • Cardiology
  • Oncology
  • General Imaging
  • Neurology
  • Others

Single-Photon Emission Computed Tomography (SPECT) Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Hospitals
  • Diagnostic Imaging Centers
  • Ambulatory Surgical Centers
  • Others

Single-Photon Emission Computed Tomography (SPECT) Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Single-Photon Emission Computed Tomography (SPECT) Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies single-photon emission computed tomography (SPECT) companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the single-photon emission computed tomography (SPECT) companies profiled in this report include-

  • Siemens Healthineers
  • Bruker
  • Toshiba Medical
  • Digirad
  • Esaote
  • Invicro
  • GE Healthcare

Single-Photon Emission Computed Tomography (SPECT) Market Insights

  • Lucintel forecasts that standalone SPECT is expected to witness higher growth over the forecast period due to its significant use in the cancer and cardiovascular divisions.
  • Within this market, hospital will remain the largest segment due to growing numbers of patients being admitted to hospitals and rising adoption of SPECT equipment for diagnosis in this facility.
  • North America is expected to witness highest growth over the forecast period due to existence of geriatric population and increasing number of patients with heart and cancer disease in the region.

Features of the Global Single-Photon Emission Computed Tomography (SPECT) Market

  • Market Size Estimates: Single-photon emission computed tomography (SPECT) market size estimation in terms of value ($B).
  • Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
  • Segmentation Analysis: Single-photon emission computed tomography (SPECT) market size by various segments, such as by application, end use, and region. in terms of value ($B).
  • Regional Analysis: Single-photon emission computed tomography (SPECT) market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
  • Growth Opportunities: Analysis of growth opportunities in different applications, end uses, and region.s for the single-photon emission computed tomography (SPECT) market.
  • Strategic Analysis: This includes M&A, new product development, and competitive landscape of the single-photon emission computed tomography (SPECT) market.
  • Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1. What is the single-photon emission computed tomography (SPECT) market size?

Answer: The global single-photon emission computed tomography (SPECT) market is expected to reach an estimated $10.5 billion by 2030.

Q.2. What is the growth forecast for single-photon emission computed tomography (SPECT) market?

Answer: The global single-photon emission computed tomography (SPECT) market is expected to grow with a CAGR of 10.0% from 2024 to 2030.

Q.3. What are the major drivers influencing the growth of the single-photon emission computed tomography (SPECT) market?

Answer: The major drivers for this market are rapid growth in healthcare industry, rising prevalence of chronic diseases, including malignancies and cardiovascular, and increasing preference for dual-modality and organ-specific systems.

Q.4. What are the major segments for single-photon emission computed tomography (SPECT) market?

Answer: The future of the single-photon emission computed tomography (SPECT) market looks promising with opportunities in the hospital, diagnostic imaging center, and ambulatory surgical center markets.

Q.5. Who are the key single-photon emission computed tomography (SPECT) market companies?

Answer: Some of the key single-photon emission computed tomography (SPECT) companies are as follows:

  • Siemens Healthineers
  • Bruker
  • Toshiba Medical
  • Digirad
  • Esaote
  • Invicro
  • GE Healthcare

Q.6. Which single-photon emission computed tomography (SPECT) market segment will be the largest in future?

Answer: Lucintel forecasts that standalone SPECT is expected to witness higher growth over the forecast period due to its significant use in the cancer and cardiovascular divisions.

Q.7. In single-photon emission computed tomography (SPECT) market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast period due to existence of geriatric population and increasing number of patients with heart and cancer disease in the region.

Q.8. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the single-photon emission computed tomography (SPECT) market by product (standalone SPECT and hybrid SPECT), application (cardiology, oncology, general imaging, neurology, and others), end use (hospitals, diagnostic imaging centers, ambulatory surgical centers, and others)and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Single-Photon Emission Computed Tomography (SPECT) Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Single-Photon Emission Computed Tomography (SPECT) Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Single-Photon Emission Computed Tomography (SPECT) Market by Product
    • 3.3.1: Standalone SPECT
    • 3.3.2: Hybrid SPECT
  • 3.4: Global Single-Photon Emission Computed Tomography (SPECT) Market by Application
    • 3.4.1: Cardiology
    • 3.4.2: Oncology
    • 3.4.3: General Imaging
    • 3.4.4: Neurology
    • 3.4.5: Others
  • 3.5: Global Single-Photon Emission Computed Tomography (SPECT) Market by End Use
    • 3.5.1: Hospitals
    • 3.5.2: Diagnostic Imaging Centers
    • 3.5.3: Ambulatory Surgical Centers
    • 3.5.4: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Single-Photon Emission Computed Tomography (SPECT) Market by Region
  • 4.2: North American Single-Photon Emission Computed Tomography (SPECT) Market
    • 4.2.2: North American Single-Photon Emission Computed Tomography (SPECT) Market by End Use: Hospitals, Diagnostic Imaging Centers, Ambulatory Surgical Centers, and Others
  • 4.3: European Single-Photon Emission Computed Tomography (SPECT) Market
    • 4.3.1: European Single-Photon Emission Computed Tomography (SPECT) Market by Product: Standalone SPECT and Hybrid SPECT
    • 4.3.2: European Single-Photon Emission Computed Tomography (SPECT) Market by End Use: Hospitals, Diagnostic Imaging Centers, Ambulatory Surgical Centers, and Others
  • 4.4: APAC Single-Photon Emission Computed Tomography (SPECT) Market
    • 4.4.1: APAC Single-Photon Emission Computed Tomography (SPECT) Market by Product: Standalone SPECT and Hybrid SPECT
    • 4.4.2: APAC Single-Photon Emission Computed Tomography (SPECT) Market by End Use: Hospitals, Diagnostic Imaging Centers, Ambulatory Surgical Centers, and Others
  • 4.5: ROW Single-Photon Emission Computed Tomography (SPECT) Market
    • 4.5.1: ROW Single-Photon Emission Computed Tomography (SPECT) Market by Product: Standalone SPECT and Hybrid SPECT
    • 4.5.2: ROW Single-Photon Emission Computed Tomography (SPECT) Market by End Use: Hospitals, Diagnostic Imaging Centers, Ambulatory Surgical Centers, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Single-Photon Emission Computed Tomography (SPECT) Market by Product
    • 6.1.2: Growth Opportunities for the Global Single-Photon Emission Computed Tomography (SPECT) Market by Application
    • 6.1.3: Growth Opportunities for the Global Single-Photon Emission Computed Tomography (SPECT) Market by End Use
    • 6.1.4: Growth Opportunities for the Global Single-Photon Emission Computed Tomography (SPECT) Market by Region
  • 6.2: Emerging Trends in the Global Single-Photon Emission Computed Tomography (SPECT) Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Single-Photon Emission Computed Tomography (SPECT) Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Single-Photon Emission Computed Tomography (SPECT) Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Siemens Healthineers
  • 7.2: Bruker
  • 7.3: Toshiba Medical
  • 7.4: Digirad
  • 7.5: Esaote
  • 7.6: Invicro
  • 7.7: GE Healthcare